vzw farmaka asbl

What vzw farmaka asbl does

vzw Farmaka asbl is a Belgian non-profit scientific organization (enterprise number 0412.024.227) founded in 2003 and headquartered in Ghent, with a registered office in Brussels. It produces evidence-based medicine (EBM) information and rational drug use guidance for Belgian healthcare professionals — primarily general practitioners, but also pharmacists, medical specialists, and nurses/caregivers — with a particular focus on elderly care pharmacotherapy through the Formularium Ouderenzorg (Formulaire de soins aux Personnes Âgées). The organization is governed by a General Assembly and Board of Directors drawn from GPs, pharmacists, specialists, and Belgian health mutual organizations (MC, UNMS, Union des Mutualités Socialistes, Mutualités Libres, Mutualité Chrétienne), and operates under HONcode certification, with no advertising accepted and no ties to the pharmaceutical industry.

Core offerings include the Formularium Ouderenzorg prescription guide, Geneesmiddelenbrieven/Formulier-Info newsletters, Fiches de Transparantie (transparency fiches), and consensus conference preparation for RIZIV/INAMI. Since 2018, the Ministry of Health terminated the Onafhankelijke ArtsenBezoekers (Independent Medical Visitors) program, and Farmaka transferred activities, archives, and staff to BCFI/CBIP (Belgian Centre for Pharmacotherapeutic Information). Content is now distributed via the BCFI platform (farmaka.bcfi.be, ft.cbip.be), with interactive e-learning modules in development.

The business model is non-commercial: Farmaka is funded through Belgian government health insurance (RIZIV/INAMI) programs and provides services free of charge to medical professionals. The organization has ~45 collaborators across editorial, research, and support roles, and is currently in a transitional state — its field outreach model has been discontinued, with operations increasingly subsumed into BCFI while the entity evaluates future initiatives.

Name

vzw farmaka asbl

Legal name

vzw Farmaka asbl

Website

https://farmaka.be

Company type

Private

Founded year

2003

Operating status

Operating

Headcount range

1–10 employees

Short description

Belgian non-profit scientific organization (vzw/asbl) that produces independent, evidence-based drug information and the Formularium Ouderenzorg for general practitioners, pharmacists, specialists, and nurses, funded by RIZIV/INAMI.

Ownership category

akta.pro rank

Product category

Pharmacotherapy Information Services

NAICS

Research and Development in the Physical, Engineering, and Life Sciences (54171)

SIC

Services-Commercial Physical & Biological Research (8731)

akta.pro primary industry

Market Access, Pricing & Reimbursement (Evidence Generation) FSP (HLAGAOAN)

akta.pro secondary industry

Healthcare Outcomes & Real-World Evidence (RWE) Analytics (BPAHALAN)

Keywords

• Evidence-based medicine
• Pharmacotherapy information
• Rational drug use
• Elderly care formulary
• Drug transparency

Headquarters

HQ city

Gent

HQ country

Belgium

HQ region

Europe

Offices2 records

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Operations, Technology or R&D, Others

Revenue model

1. Public/Government Funding: Farmaka vzw operates as a non-profit scientific organization funded through government health insurance (RIZIV/INAMI) programs. The organization publishes independent drug information without commercial funding to maintain objectivity. No advertising is accepted, and no financial ties exist with pharmaceutical companies.

Go-to-market motion1 record

Distribution channels2 records

Marketing channels4 records

Core offering

vzw Farmaka asbl is an independent Belgian non-profit scientific organization that produces and disseminates evidence-based medicine (EBM) information to support rational drug use among general practitioners, pharmacists, specialists, and nurses. Its core offerings include the Formularium Ouderenzorg (an evidence-based prescribing guide for elderly patients), the Geneesmiddelenbrieven/Formulier-Info newsletters, transparancy fiches on medications, and consensus conference preparation for RIZIV/INAMI, all delivered free of charge and without pharmaceutical industry funding.

Product overview

Farmaka vzw/asbl is an independent scientific organization providing evidence-based medicine (EBM) information for general practitioners and rational use of medications in Belgium. The organization offers a portfolio of products including the Formularium Ouderenzorg (Formulaire de soins aux Personnes Agées), a prescription guide for elderly patients, Geneesmiddelenbrieven/Formulier-Info newsletters, and Fiches de Transparantie transparency documents. The Independent Medical Visitors service has been discontinued, with activities transferred to the Belgian Center for Pharmacotherapeutic Information (BCFI/CBIP). E-learning modules are currently under development in partnership with BCFI.

Differentiator

Problem solved

Functional benefit

Quantifiable outcome

• Formularium Ouderenzorg provides prescribing guidance for elderly patients, serving as replacement for discontinued independent medical visitor visits
• +1 more outcomes

Named customers4 records

Segments4 records

Ideal customer profiles4 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Partnerships

One partnership is on record.

• BCFI/CBIP (Belgian Centre for Pharmacotherapeutic Information)coreStrategic or Co-development Partner · 1 January 2018Following the Ministry of Health's decision to discontinue the independent medical visitor project, Farmaka transferred activities and staff to BCFI/CBIP. The Formularium Ouderenzorg and preparation of INAMI consensus conferences are now managed by BCFI. Farmaka's documentation and archives remain accessible through BCFI's platform. The combined team forms a strengthened BCFI organization continuing independent drug information services.

Scale indicators2 records

Recent moves7 records

Expansion highlights4 records

Regional players

• IQWiG (Institute for Quality and Efficiency in Health Care): Germany's HTA body producing evidence-based reports for G-BA reimbursement decisions. Comparable to Farmaka's market access evidence-generation role, but operates at national scale for the German market.
• Zorginstituut Nederland (ZIN): Dutch national HTA and reimbursement authority that advises on the basic health insurance package. Functionally analogous to RIZIV/INAMI plus KCE, with which Farmaka works on the Belgian side.
• HAS (Haute Autorité de Santé): French national HTA authority producing clinical guidelines and health technology assessments. Operates in a similar reimbursement-policy context to RIZIV/INAMI, but serves French clinicians and is not active in Belgium.
• CADTH (Canadian Agency for Drugs and Technologies in Health): Canadian HTA agency producing reimbursement recommendations and evidence-based guidance for formulary managers and clinicians. Comparable market access evidence-generation function, but serves Canada rather than Belgium.
• TLV (Swedish Dental and Pharmaceutical Benefits Agency): Swedish agency deciding which pharmaceuticals are subsidized through the national benefits scheme. Comparable to RIZIV in scope and to Farmaka's market access evidence role, but operates in a different national market.

Broad incumbents

• NICE (National Institute for Health and Care Excellence): UK national HTA body producing clinical guidelines and technology appraisals for the NHS. Far broader scope than Farmaka, but shares the function of converting evidence into prescribing guidance that influences national reimbursement decisions.
• AHRQ (Agency for Healthcare Research and Quality): US federal agency funding comparative effectiveness research and producing evidence-based clinical resources. Operates at much larger scale and across more clinical areas, but shares the mission of converting evidence into clinician-facing guidance.

Direct peers

• KCE (Belgian Health Care Knowledge Centre): Belgian federal HTA and health services research body that produces evidence-based reports to inform RIZIV/INAMI reimbursement and policy decisions. Comparable to Farmaka's consensus conference preparation function in scope and target audience.
• BCFI/CBIP (Belgian Centre for Pharmacotherapeutic Information): National Belgian centre providing independent drug information to prescribers and pharmacists. Farmaka transferred its operational activities and staff to BCFI in 2018, making BCFI the principal operational counterpart and the closest direct peer in mission and audience.

Others

• Cochrane: Independent global network producing systematic reviews and evidence syntheses used by HTA bodies and guideline developers. Farmaka explicitly sources its evidence from "recognised EBM producers" including Cochrane, making it a key upstream evidence supplier rather than a competitor.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks6 records

Key highlights7 records

Customer concentration

• LinkedInlinkedin.com/company/vzw-farmaka-asbl

Compliance1 record

Revenue estimate

Valuation estimate

Number of profiles

Profiles20 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about vzw farmaka asbl